Trilaciclib
Product Specifications
CAS Number
1374743-00-6
Target
Cell Cycle Arrest, CDK
Related Pathways
Cell Cycle/Checkpoint
Purity
0.99624
Bioactivity
Trilaciclib is a short-acting, orally effective CDK4/6 inhibitor with IC50 values of 1 nM and 4 nM respectively. It transiently and reversibly induces G1 cell cycle arrest, mitigates chemotherapy-induced myelosuppression, and enhances antitumour immunity, making it applicable across multiple cancers.
Smiles
CN1CCN(CC1)c1ccc(Nc2ncc3cc4C(=O)NCC5(CCCCC5)n4c3n2)nc1
Molecular Formula
C24H30N8O
Molecular Weight
446.55
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog